combination therapy with glp-1 receptor agonist and sglt2 inhibitor Blood pressure effects of inhibitors GLP‐1 agonists: Mechanisms, trial evidence and Real‐world data - Belančić - British Journal of Clinical Pharmacology 3. Integration of GLP-1RA or
Description
The potent and reliable metabolic effects, coupled with ease of administration, make Ozempic the leading GLP-1 product globally, capturing the largest market share
Rahemi H, Nigam N, Wakeling JM
Although the use of GLP-1 RAs prior to EGD or colonoscopy has resulted in poor outcomes in terms of poor visibility/preparation scores and the need for aborted/repeated procedures, their use prior to concurrent EGD and colonoscopy might not have the same detrimental effect
Am J Physiol Gastrointest Liver Physiol
